首页 › 基金 › SUPERSTRING CAPITAL MANAGEMENT LP › CABA
SUPERSTRING CAPITAL MANAGEMENT LP 对 CABA 的持仓历史
CABALETTA BIO INC · 医疗保健
SUPERSTRING CAPITAL MANAGEMENT LP 在 Q2 2026 的 13F 申报中披露持有 CABA(CABALETTA BIO INC)1,278,652 股,市值约 US$3.5M,约占其申报组合的 2.20%,在其申报持仓中市值排名第 19 位。 SUPERSTRING CAPITAL MANAGEMENT LP 最近 10 个申报季度中有 10 个季度披露了 CABA 持仓,最早可追溯至 Q1 2024。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
SUPERSTRING CAPITAL MANAGEMENT LP 对 CABA 的持仓演变
SUPERSTRING CAPITAL MANAGEMENT LP 于 Q1 2024 首次披露 CABA 持仓:290,797 股(约 US$5.0M)。 在 10 次申报中,SUPERSTRING CAPITAL MANAGEMENT LP 5 次增持、4 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 1,278,652 股、市值约 US$3.5M,环比增持 212,413 股。。 持仓曾出现大幅变动:Q4 2024 增持约 524% (随后一个季度股价下跌 39%)、Q2 2025 增持约 131% (随后一个季度股价上涨 54%)、Q1 2026 减持约 53% (随后一个季度股价上涨 16%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2024 | 290.80K | $4.96M | 新进 |
| Q2 2024 | 139.90K | $1.05M | 减持 |
| Q3 2024 | 131.79K | $622.07K | 减持 |
| Q4 2024 | 822.29K | $1.87M | 增持 |
| Q1 2025 | 458.97K | $635.68K | 减持 |
| Q2 2025 | 1.06M | $1.61M | 增持 |
| Q3 2025 | 1.54M | $3.61M | 增持 |
| Q4 2025 | 2.25M | $4.94M | 增持 |
| Q1 2026 | 1.07M | $2.87M | 减持 |
| Q2 2026 | 1.28M | $3.48M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 CABA 与 13F 数据
CABA(CABALETTA BIO INC)属于医疗保健行业。我们追踪的基金中还有 37 只申报持有 CABA,申报仓位最大的包括:Bain Capital Life Sciences Investors, LLC (US$53.6M), Cormorant Asset Management, LP (US$15.6M), Opaleye Management Inc. (US$12.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 CABA 的基金
- Bain Capital Life Sciences Investors, LLC 17.24M 股 · $53.62M · Q2 2026
- Cormorant Asset Management, LP 5.00M 股 · $15.55M · Q2 2026
- Opaleye Management Inc. 3.86M 股 · $12.02M · Q2 2026
- Stonepine Capital Management, LLC 917.10K 股 · $2.85M · Q2 2026
- Blue Owl Capital Holdings LP 714.71K 股 · $2.22M · Q2 2026
更多关于 SUPERSTRING CAPITAL MANAGEMENT LP
常见问题
How long has SUPERSTRING CAPITAL MANAGEMENT LP held CABA?
SUPERSTRING CAPITAL MANAGEMENT LP has disclosed CABA holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in CABA?
As of Q2 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 1.28M shares of CABA (CABALETTA BIO INC), valued at $3.48M, representing 2.20% of its reported portfolio and ranking #19.
Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling CABA?
In the latest 13F filing (Q2 2026), SUPERSTRING CAPITAL MANAGEMENT LP increased its position in CABA.
Which other funds hold CABA?
Other major institutional holders of CABA include Bain Capital Life Sciences Investors, LLC, Cormorant Asset Management, LP, Opaleye Management Inc., among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.